Lonza has announced that its Center of Excellence for respiratory formulations in Bend, OR, US can now offer kilogram scale spray drying of proteins for inhalation. With the latest expansion, the company is now able to serve customers who need clinical and/or commercial manufacturing for protein DPI formulations.
Lonza Director, Respiratory Delivery, Kimberly Shepard commented, “Pulmonary delivery of solid protein formulations using a dry powder inhaler is a growing trend among drug developers. Our new clinical offering further strengthens our world-leading spray drying expertise and provides manufacturing capacity from early phase to commercial supply. This expertise and capability enable our customers to bring innovative new medicines to patients with unmet medical needs.”
Read the Lonza press release.
